Non-Deal Roadshow

News & Media Contact Access Your Account Careers Corporate Access

Nov 3 2026 Tuesday

Cel Sci Corp. (NYSE American: CVM)

CEL-SCI Corporation is a late clinical-stage biotechnology company. It is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. It is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS).
For more information including SEC filings please visit: https://cel-sci.com/

A * denotes a required field

We're sorry, but this form has spam protection that requires JavaScript to be enabled to work correctly. If you'd like to contact us via this form, please enable JavaScript in your browser and reload the page.

First Name*

Last Name*

Fund

Your Rep's Email Address*

Email Address*

Phone Number*

This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.